Case Reports in Gastroenterology (Oct 2020)

STK11 p.F354L Germline Mutation in a Case of Multiple Gastrointestinal Tumors

  • Yohei Kojima,
  • Kouki Ohtsuka,
  • Shun Ishii,
  • Nobuyoshi Aso,
  • Atsuko Ohki,
  • Yoshikazu Hashimoto,
  • Hirohisa Takeuchi,
  • Hiroaki Ohnishi,
  • Nobutsugu Abe

DOI
https://doi.org/10.1159/000508929
Journal volume & issue
Vol. 14, no. 3
pp. 547 – 553

Abstract

Read online

Serine/threonine kinase 11 (STK11) is known as a critical tumor-suppressor gene that is frequently mutated in a broad spectrum of human cancers. Among these, the p.F354L mutation of STK11 has been identified in sporadic colon or lung cancer cases. Here, we report the case of a 75-year-old male patient who underwent surgical treatment for multiple tumors of the gastrointestinal system. Genetic mutations were screened in all resected samples, including duodenal high-grade adenoma, gastric high-grade adenoma, rectal adenocarcinoma, and liver metastasis of rectal adenocarcinoma, by next-generation sequencing for mutational hotspots involving 50 oncogenes and tumor suppressor genes. The characteristic hamartomatous polyp of Peutz-Jeghers syndrome was not detected in any tumor specimen. However, all samples as well as the normal rectal mucosa harbored the genetic mutation p.F354L in STK11. In addition, somatic mutations coexisted in the tumor samples, including KRAS p.A146T, TP53 p.G238X, and APC p.T1556fs in the duodenal adenoma; TP53 p.G238Y and APC p.T1556fs in the gastric adenoma; and TP53 p.R282W in the rectal adenocarcinoma and metastatic liver cancer. No somatic mutation was detected in the normal rectal mucosa as a control sample. To our knowledge, this is the first report of an STK11 germline mutation in a patient with multiple tumors of the gastrointestinal tract.

Keywords